A Memorandum of Understanding (MOU) signed by the Virginia Innovation Partnership Corporation (VIPC) and AstraZeneca, Eli Lilly (Lilly), and Merck to develop the Virginia Center for Advanced ...

Novartis' two new sites in North Carolina fall under the Swiss pharma’s $23bn US manufacturing onshoring ploy.

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a ...

Starting in 2026, NIBRT training will be piloted at Heartland BioWorks’ Indianapolis headquarters with hands-on training beginning in 2027.

Tariff pressures, a changing regulatory environment, and risk-averse investors have left many Cambridge biotechnology ...

Evon Walters, Flavius R.W. Lilly and Rai Kathuria, Clark State College's three finalists as the next president, presented during open forums.

Denmark is heading for its worst year of job losses since the Covid pandemic, as sweeping cuts at pharmaceutical giant Novo ...

Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination ...

The U.S. pharmacy benefits industry, a $500 billion sector, is dominated by just four Pharmacy Benefit Managers (PBMs) controlling 67% of the market. (1,2) This concentration leads to inflated drug ...

Building on an enviable talent base, the commonwealth has developed a complete innovation ecosystem—from breakthrough ...